GSA Capital Partners’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

GSA Capital Partners’s Portfolio KNTE Stock Details KNTE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell
2024 Q1	$890K	Sell
2023 Q4	$803K	Sell
2023 Q3	$524K	Buy
2023 Q2	$728K	Buy
2023 Q1	$232K	Sell
2022 Q4	$428K	Sell
2022 Q3	$876K	Buy
2022 Q2	$711K	Buy
2022 Q1	$531K	Buy